Chembond Material Technologies Reports Mixed Q2 FY26 Results; Revenue Up, Profit Down
Chembond Material Technologies reported Q2 FY26 results with revenue growth but a significant decline in consolidated and standalone profits compared to previous periods, impacting overall profitability.
The announcement contains the company's financial results for the quarter and half-year, which are critical performance indicators for investors and directly influence stock valuation and market perception.
Despite a modest increase in revenue from operations, the company experienced a significant decline in both consolidated and standalone Profit Before Tax and Profit After Tax for Q2 FY26 compared to both the previous quarter and the same quarter last year, indicating a substantial hit to profitability.
Chembond Material Technologies Limited announced its unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2025, approved by the Board of Directors at their meeting held on October 17, 2025. * Consolidated Financial Highlights for Q2 FY26 (July-September 2025): * Revenue from operations stood at ₹5,775.01 lakhs, a slight increase from ₹5,767.50 lakhs in Q1 FY26 and up from ₹4,977.62 lakhs in Q2 FY25. * Profit Before Tax (PBT) was ₹284.76 lakhs, a significant decrease from ₹536.53 lakhs in Q1 FY26 and ₹708.23 lakhs in Q2 FY25. * Profit For the Period (PAT) was ₹382.71 lakhs, down from ₹399.02 lakhs in Q1 FY26 and ₹629.36 lakhs in Q2 FY25. * Basic Earnings Per Share (EPS) decreased to ₹2.85 from ₹4.68 in Q2 FY25. * Consolidated Financial Highlights for Half Year FY26 (April-September 2025): * Revenue from operations was ₹11,542.51 lakhs, an increase from ₹9,604.41 lakhs in H1 FY25. * Profit Before Tax (PBT) was ₹821.29 lakhs, down from ₹1,187.33 lakhs in H1 FY25. * Profit For the Period (PAT) was ₹781.73 lakhs, down from ₹1,097.10 lakhs in H1 FY25. * Segment-wise Performance (Consolidated Q2 FY26): * Specialty Chemical segment revenue was ₹5,045.29 lakhs with Profit/Loss Before Interest & Tax (PBIT) of ₹149.06 lakhs. * Animal Health segment revenue was ₹1,007.43 lakhs with PBIT of ₹123.14 lakhs. * Standalone Financial Highlights for Q2 FY26: * Revenue from operations was ₹4,893.32 lakhs, slightly up from ₹4,892.03 lakhs in Q1 FY26 and ₹4,302.40 lakhs in Q2 FY25. * Profit Before Tax (PBT) was ₹158.78 lakhs, significantly down from ₹457.28 lakhs in Q1 FY26 and ₹715.40 lakhs in Q2 FY25. * Profit For the Period (PAT) was ₹263.12 lakhs, down from ₹316.95 lakhs in Q1 FY26 and ₹634.07 lakhs in Q2 FY25. * The comparative figures for the quarter and half year ended September 30, 2024, have been restated due to a Composite Scheme of Arrangement (demerger and amalgamation) pursuant to an NCLT order dated April 7, 2025. * The trading window for dealing in company securities remained closed for designated persons and their immediate relatives until September 19, 2025, following the Board meeting outcome.
What to do with a filing like this
Chembond Material Technologies Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chembond Material Technologies Limited. Read the original for the full detail.